Voloridge Investment Management, LLC Bei Gene, Ltd. Transaction History

Voloridge Investment Management, LLC

$26.2 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$179.87 - $225.13 $2.37 Million - $2.96 Million	-13,159 Reduced 56.12%	10,291 $1.85 Million
Q2 2023 Aug 14, 2023	BUY	$178.3 - $266.78 $1.63 Million - $2.44 Million	9,128 Added 63.73%	23,450 $4.18 Million
Q1 2023 May 15, 2023	BUY	$215.53 - $274.5 $3.09 Million - $3.93 Million	14,322 New	14,322 $3.09 Million
Q3 2022 Nov 14, 2022	BUY	$131.8 - $202.24 $1.35 Million - $2.08 Million	10,275 New	10,275 $1.39 Million
Q3 2021 Nov 15, 2021	SELL	$249.6 - $403.14 $1.79 Million - $2.89 Million	-7,171 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$292.75 - $367.01 $362,131 - $453,991	-1,237 Reduced 14.71%	7,171 $2.46 Million
Q1 2021 May 17, 2021	SELL	$260.64 - $382.12 $4.9 Million - $7.18 Million	-18,797 Reduced 69.09%	8,408 $2.93 Million
Q4 2020 Feb 16, 2021	BUY	$221.31 - $316.61 $6.02 Million - $8.61 Million	27,205 New	27,205 $7.03 Million
Q1 2020 May 15, 2020	SELL	$121.84 - $173.19 $4.94 Million - $7.02 Million	-40,541 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$115.78 - $208.34 $4.26 Million - $7.67 Million	36,812 Added 987.18%	40,541 $6.72 Million
Q3 2019 Nov 14, 2019	BUY	$120.61 - $148.29 $221,922 - $272,853	1,840 Added 97.41%	3,729 $457,000
Q2 2019 Aug 14, 2019	BUY	$113.99 - $146.86 $215,327 - $277,418	1,889 New	1,889 $234,000
Q3 2018 Nov 14, 2018	SELL	$152.62 - $189.66 $1.91 Million - $2.37 Million	-12,521 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$152.5 - $216.77 $1.24 Million - $1.76 Million	8,121 Added 184.57%	12,521 $1.93 Million
Q1 2018 May 15, 2018	BUY	$97.41 - $177.22 $428,604 - $779,768	4,400 New	4,400 $739,000

Others Institutions Holding BGNE

# of Institutions

252

Shares Held

45.3M

Call Options Held

292K

Put Options Held

119K

Baker Bros. Advisors LP New York, NY

10.6M
Shares

$1.89 Billion
25.41% of portfolio
Capital International Investors Los Angeles, CA

6.43M
Shares

$1.15 Billion
0.29% of portfolio
Hhlr Advisors, Ltd. Grand Cayman, E9

5.18M
Shares

$927 Million
26.65% of portfolio
Primecap Management CO Pasadena, CA

4.97M
Shares

$891 Million
0.84% of portfolio
Baillie Gifford & CO

3.71M
Shares

$664 Million
0.64% of portfolio

View Full List

About BeiGene, Ltd.

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $18.6B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

More about BGNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.

Account